0341 GMT - Life360 has the flexibility to manage potential dilution from its convertible note offering, MS analysts say. They tell clients that the tracking-app provider's raise strengthens its balance sheet through to fiscal 2030 at a very attractive rate. The trade-off is potential dilution if the dual-listed company's U.S. stock passes US$122.22 a share. They think that the structure of the notes and the strength of performance that would be required for the stock to trade at such levels provide Life360 with options to manage the scenario. MS has an overweight recommendation and A$32.00 target price on Life360's Australia-listed shares, which are down 1.7% at A$32.675. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
June 09, 2025 23:41 ET (03:41 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.